Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (RH0-D) immune globulin

American Journal of Tropical Medicine and Hygiene

Volumn 76, Issue 4, 2007, Pages 737-742

  De Castro, Reynaldo Angelo C ^b,c,d,e   De Castro, Jo Anne A ^b   Barez, Marie Yvette C ^f   Frias, Melchor V ^b   Dixit, Jitendra ^a   Genereux, Maurice ^a  

^a Cangene Corporation   (Canada)

^b DE LA SALLE UNIVERSITY   (Philippines)

^c FAR EASTERN UNIVERSITY   (Philippines)

^d Philippine Children's Medical Center   (Philippines)

^e Amang Rodriguez Medical Center   (Philippines)

^f Davao Medical School Foundation   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RHESUS D ANTIBODY;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DESTRUCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; FEMALE; HUMAN; MALE; MORTALITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ADULT; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; FEMALE; HUMANS; MALE; RHO(D) IMMUNE GLOBULIN; THROMBOCYTOPENIA;

EID: 34249702311     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.76.737     Document Type: Article

References (9)